Rare Medical Case: Body Donor Found to Have Triphallia Condition
A man who donated his body to medical science was discovered during autopsy to have triphallia, an extremely rare congenital condition involving three penises. The condition is so uncommon that only a handful of cases have been documented in medical literature. The discovery highlights how rare anatomical variations can go undetected during life and become valuable for medical education and research.
During a routine autopsy of a body donor, medical professionals identified triphallia—a congenital condition characterized by the presence of three penises—in the deceased individual. This condition is extraordinarily rare, with only a small number of documented cases in medical history, making the discovery medically significant. The finding presented a diagnostic dilemma for the medical team, as such extreme anatomical variations are typically unknown to the individuals who have them and may not be detected without direct examination. The case underscores how body donation programs contribute to medical knowledge by revealing unusual anatomical conditions that can inform clinical understanding and medical education. Such rare presentations help expand the medical literature and improve clinicians' awareness of possible congenital variations.
What's missing
The specific medical journal or institution where this case was documented, the individual's age and medical history, and whether the condition was associated with any other health complications or symptoms during life are not provided in the available material.
What different sources said
- Live ScienceCenter
Diagnostic dilemma: Man who donated his body after death had rare 'triple penis'
Related
Multi-Cancer Blood Test Galleri Fails Primary Trial Endpoint
A major clinical trial of Galleri, a blood test designed to detect multiple cancers early, failed to meet its primary goal of reducing late-stage cancer diagnoses when results were announced in February. Multi-cancer early detection (MCED) tests aim to improve survival rates by identifying disease at earlier, more treatable stages. The failure raises questions about the effectiveness of this promising diagnostic approach despite initial scientific enthusiasm.
Study Uses CPAP Data to Measure Social Jet Lag in Sleep Apnea Patients
Researchers analyzed CPAP adherence records from nearly 3,000 obstructive sleep apnea patients to measure social jet lag—the circadian misalignment between work and free days. About 16-21% of patients showed moderate to severe social jet lag, with prevalence highest in younger and middle-aged adults and declining after age 65. The findings suggest CPAP devices could routinely screen for circadian misalignment, potentially identifying patients who need additional behavioral or activity-based interventions.
FDA Updates Alli Label to Warn of Rare but Potentially Fatal Kidney Problems
The FDA has approved updated labeling for Alli, an over-the-counter weight loss pill, to warn of rare risks including acute kidney injury, kidney stones, and oxalate nephropathy. The agency now instructs people with kidney disease history to consult a doctor before use and directs all users to stop taking the drug if they experience symptoms like back pain, blood in urine, or leg swelling. This warning is significant because Alli is the only OTC weight loss medication available in the U.S., and approximately 40 million people have used orlistat (Alli's generic form) since its approval in 1999.